Department of Anesthesiology, Wayne State University School of Medicine, Detroit.
Department of Anesthesiology, St. Joseph Mercy Oakland Hospital, Pontiac, MI.
Clin J Pain. 2022 Jun 1;38(6):388-395. doi: 10.1097/AJP.0000000000001036.
Adequate pain management is a critical component of facilitating same-day discharge for total knee arthroplasty (TKA). Adductor canal blocks (ACB) have been shown to be an effective technique for managing pain after TKA. The objective of this study was to investigate the impact of adding magnesium to local anesthetic in ACB on postoperative pain, opioid consumption, nausea, and overall patient satisfaction.
A sample of 119 adults undergoing elective unilateral TKA were included. Patients were randomly assigned to receive ACB with magnesium and bupivacaine (n=56) or with bupivacaine only (n=63). Primary outcomes were total opioid consumption in the first 48 hours after surgery and pain scores. Secondary outcomes were the incidence of nausea in the first 48 hours after surgery and total overall satisfaction.
Opioid consumption decreased significantly in the Mg group compared with the no-Mg group over the first 24 hours (33.2±3.0 vs. 21.3±2.4, P=0.003), the second 24 hours (35.4±2.7 vs. 27.3±2.3, P=0.026), and the first 48 hours total after surgery (68.6±5.1 vs. 48.6±4.3, P=0.004). Pain scores were reduced in the Mg group (24 h: 5.1±2.3 vs. 3.5±2.0, P=0.000; 48 h: 5.1±1.6 vs. 3.9±1.6, P=0.000). Secondary outcomes showed no difference in the incidence of nausea over the first 48 hours and overall satisfaction.
The addition of magnesium to local anesthetic in ACB decreases pain scores and opioid consumption, without increasing nausea, when compared with ACB with local anesthetic alone.
充分的疼痛管理是促进全膝关节置换术(TKA)当天出院的关键组成部分。股神经沟阻滞(ACB)已被证明是一种有效的 TKA 后止痛技术。本研究的目的是探讨在 ACB 中加入镁对局部麻醉剂对术后疼痛、阿片类药物消耗、恶心和整体患者满意度的影响。
纳入 119 名接受择期单侧 TKA 的成年人。患者随机分配接受 ACB 联合镁和布比卡因(n=56)或仅接受布比卡因(n=63)。主要结局是术后 48 小时内的总阿片类药物消耗量和疼痛评分。次要结局是术后 48 小时内恶心的发生率和总总体满意度。
与无镁组相比,镁组在术后 24 小时(33.2±3.0 比 21.3±2.4,P=0.003)、48 小时(35.4±2.7 比 27.3±2.3,P=0.026)和术后 48 小时内总阿片类药物消耗明显减少(68.6±5.1 比 48.6±4.3,P=0.004)。镁组疼痛评分降低(24 小时:5.1±2.3 比 3.5±2.0,P=0.000;48 小时:5.1±1.6 比 3.9±1.6,P=0.000)。次要结局显示,术后 48 小时内恶心的发生率和总体满意度无差异。
与单独使用 ACB 中的局部麻醉剂相比,在 ACB 中加入镁可降低疼痛评分和阿片类药物消耗,而不会增加恶心。